| Title | Oncotarget |
| Abbreviation | Oncotarget |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Oncology (Q2) |
| h-index | 165 |
| Overall Rank/Ranking | 5969 |
| SCImago Journal Rank (SJR) | 0.801 |
| Impact Score | 2.54 |
| Publisher | Impact Journals LLC |
| Country | United States |
| ISSN | 19492553 |
| Best Quartile | Q2 |
| Coverage History | 2010-2022 |
| Official Website | Visit Website |
| Wikipedia Page | Visit Wikipedia |
Oncotarget (a primarily oncology-focused, peer-reviewed, open access, biweekly journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing OncoTarget.
From January 1, 2021 Oncotarget is a biweekly journal that is published on Tuesday.
Oncotarget is a journal covering the technologies/fields/categories related to Oncology (Q2). It is published by Impact Journals LLC. The overall rank of Oncotarget is 5969. According to SCImago Journal Rank (SJR), this journal is ranked 0.801. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 165. The best quartile for this journal is Q2.
The ISSN of Oncotarget journal is 19492553. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Oncotarget is cited by a total of 3369 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Oncotarget is 2.54, which is computed in 2023 as per its definition. Oncotarget IF is decreased by a factor of 0.12 and approximate percentage change is -4.51% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Oncotarget is 2.54. If the same downward trend persists, Impact IF may fall in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.54 |
| 2021 | 2.66 |
| 2020 | 3.34 |
| 2019 | 3.67 |
| 2018 | 3.69 |
| 2017 | 4.66 |
| 2016 | 4.95 |
| 2015 | 5.02 |
| 2014 | 5.40 |
Oncotarget has an h-index of 165. It means 165 articles of this journal have more than 165 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Oncotarget is 19492553. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Oncotarget is 5969. According to SCImago Journal Rank (SJR), this journal is ranked 0.801. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.801 |
| 2021 | 0.966 |
| 2020 | 1.373 |
| 2019 | 1.513 |
| 2018 | 1.575 |
| 2017 | 1.942 |
| 2016 | 1.994 |
| 2015 | 2.260 |
| 2014 | 2.551 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 5969 |
| 2021 | 4314 |
| 2020 | 2643 |
| 2019 | 2196 |
| 2018 | 2061 |
| 2017 | 1457 |
| 2016 | 1407 |
| 2015 | 1144 |
| 2014 | 894 |
Oncotarget is published by Impact Journals LLC. It's publishing house is located in United States. Coverage history of this journal is as following: 2010-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Oncotarget is Oncotarget. This abbreviation ('Oncotarget') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Oncology (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Oncotarget latest impact IF is 2.54. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 5.40 (2014) and 2.54 (2022), respectively, in the last 9 years. Moreover, its average IS is 3.99 in the previous 9 years.
The Oncotarget has an SJR (SCImago Journal Rank) of 0.801, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 2.551 in 2014 and the lowest being 0.801 in 2022. Furthermore, the average SJR of the Oncotarget over the previous 9-year period stands at 3.99.
The latest h-index of the Oncotarget is 165.
The Oncotarget is published by the Impact Journals LLC, with its country of publication being the United States.
The Oncotarget is currently ranked 5969 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 894 in 2014 and its lowest position of 5969 in 2022.
The standard ISO4 abbreviation for the Oncotarget is Oncotarget.
Oncotarget is classified as a journal that the Impact Journals LLC publishes.
The Oncotarget encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Oncotarget is assigned the following International Standard Serial Numbers (ISSN): 19492553.
The best quartile for the Oncotarget is Q2 (2022).
The Oncotarget coverage history can be summarized as follows: 2010-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Business: Theory and Practice | journal | 13414 | Vilnius Gediminas Technical University | 21 | 2.47 |
| Modern Language Journal | journal | 918 | Wiley-Blackwell | 103 | 3.89 |
| Journal des Professionnels de l'Enfance | journal | 27577 | TPMA | 2 | 0.00 |
| Archiv fur Geflugelkunde | journal | 28770 | Verlag Eugen Ulmer | 30 | 0.00 |
| Expert Review of Clinical Pharmacology | journal | 5241 | Taylor and Francis Ltd. | 53 | 4.10 |
| Psycho-Oncologie | journal | 24009 | Springer Paris | 11 | 0.13 |
| Journal of Digestive Diseases | journal | 5987 | Wiley-Blackwell Publishing Ltd | 59 | 2.77 |
| Perspectives in health information management / AHIMA, American Health Information Management Association | journal | 14520 | American Health Information Management Association | 28 | 0.64 |
| Acta Bioethica | journal | 23565 | Universidad de Chile - Centro Interdisciplinario de Estudios en Bioetica | 10 | 0.38 |
| Journal of Power Electronics | journal | 14181 | Korean Institute of Power Electronics | 38 | 1.69 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 2.54 |
| 2021 | 2.66 |
| 2020 | 3.34 |
| 2019 | 3.67 |
| 2018 | 3.69 |
| 2017 | 4.66 |
| 2016 | 4.95 |
| 2015 | 5.02 |
| 2014 | 5.40 |
